Bruce Japsen

Thanks to strong sales of its blood-clotting drug for hemophilia patients, Baxter International Inc. said Thursday that third-quarter profit jumped 16 percent as it hit its recently lowered sales target....

Even though Abbott Laboratories will begin temporarily giving its experimental rheumatoid arthritis treatment to patients for free, the drug could be taking a major step toward generating blockbuster sales. As...

Although Illinois hospitals' distaste for a controversial state board is well known, they don't want their primary regulator to go away. The Illinois Hospital Association two years ago successfully lobbied...

Even as Wall Street braces for a flood of lackluster third-quarter corporate-earnings reports, investors and economists are trying to get a handle on how various sectors of the local economy...

In what is becoming an annual disagreement between Chicago's medical care giants, Advocate Health Care and Blue Cross and Blue Shield of Illinois are at an impasse over payment issues....

AstraZeneca PLC confirmed recently that it was in settlement talks with federal prosecutors who have been investigating the company's marketing practices for its prostate cancer drug Zoladex during the mid-1990s....

A Chicago health-care entrepreneur is launching a new company to operate surgery centers and surgical-care hospitals, a popular choice for consumers, insurers and federal lawmakers tightening Medicare reimbursement. With the...

Loyola University Health System's bond rating has been downgraded amid thin operating margins and rising debt levels, according to a new report from Moody's Investors Service. The parent of Loyola...

Signing its first deal, a start-up specialty pharmaceutical company has acquired two drugs from Abbott Laboratories as part of a strategy to market treatments developed by major pharmaceutical companies. Lincolnshire-based...